Direct-acting oral anticoagulants (DOACs): paediatric and renal impairment – Medicines and Healthcare products Regulatory Agency

· DOACs are a group of medicines that help to prevent blood clots from forming – they are used to prevent strokes, heart attacks and other issues associated with blood clots

· parents and caregivers of children and adolescents prescribed these medicines should read and follow the Instructions for Use (IFU) booklet provided for instructions on how to prepare and administer these medicines

· all patients with renal impairment who are taking DOACs will be reviewed regularly to make sure they are taking the correct dose

· if patients or carers have any concerns about these medicines, they should talk to their healthcare professional